Lupus patients get safer shot: new vaccine strategy tested
NCT ID NCT00611663
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 19 times
Summary
This study tested two ways to give pneumococcal vaccines to 47 adults with stable lupus. One group got a prime-boost approach (conjugate vaccine first, then standard vaccine 6 months later), while the other got only the standard vaccine. The goal was to see which strategy produced a stronger immune response without causing lupus flare-ups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIC Vaccinologie - Hopital Cochin
Paris, 75679, France
Conditions
Explore the condition pages connected to this study.